Literature DB >> 27297770

Deferoxamine improves antioxidative protection in the brain of neonatal rats: The role of anoxia and body temperature.

Hanna Kletkiewicz1, Anna Nowakowska2, Agnieszka Siejka3, Celestyna Mila-Kierzenkowska4, Alina Woźniak5, Michał Caputa6, Justyna Rogalska7.   

Abstract

After hypoxic-ischemic insult iron deposited in the brain catalyzes formation of reactive oxygen species. Newborn rats, showing reduced physiological body temperature and their hyperthermic counterparts injected with deferoxamine (DF), a chelator of iron, are protected both against iron-mediated neurotoxicity and against depletion of low-molecular antioxidants after perinatal asphyxia. Therefore, we decided to study the effects of DF on activity of antioxidant enzymes (superoxide dismutase-SOD, glutathione peroxidase-GPx and catalase-CAT) in the brain of rats exposed neonatally to a critical anoxia at body temperatures elevated to 39°C. Perinatal anoxia under hyperthermic conditions intensified oxidative stress and depleted the pool of antioxidant enzymes. Both the depletion of antioxidants and lipid peroxidation were prevented by post-anoxic DF injection. The present paper evidenced that deferoxamine may act by recovering of SOD, GPx and CAT activity to reduce anoxia-induced oxidative stress.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Antioxidant enzymes; Deferoxamine; Hyperthermia; Neonatal anoxia

Mesh:

Substances:

Year:  2016        PMID: 27297770     DOI: 10.1016/j.neulet.2016.06.022

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Aerosolized deferoxamine administration in mouse model of bronchopulmonary dysplasia improve pulmonary development.

Authors:  Yanru Chen; Sha Gao; Yufei Yan; Jihong Qian; Hao Chen
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 2.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.